Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sentinel Lymph Node Detection in Patients With Stage Ib-III Melanoma Using MultiSpectral Optoacoustic Tomography (MSOT) and IndoCyanine Green (ICG)

NCT05467137 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT05467137
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05467137 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sentinel Lymph Node Detection in Patients With Stage Ib-III Melanoma Using MultiSpectral Optoacoustic Tomography (MSOT) and IndoCyanine Green (ICG)
Lead sponsor
University Medical Center Groningen
Phase
Phase 4
Overall status
Unknown status
Start date
September 30, 2022
Completion date
March 31, 2023
Enrollment
10 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma stage iii, melanoma, stage i, melanoma, stage ii